Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ret finger protein-like 4A (RFPL4A) is a protein-coding gene in humans located on chromosome 19 and predicted to encode an E3 ubiquitin protein ligase. It is thought to participate in protein ubiquitination, potentially influencing autophagy, NF-kappaB signaling, innate immune response, and regulation of gene expression. The protein may be active in the cytosol and nucleus of cells, particularly in female germ cells. No evidence was found supporting its status as a typical therapeutic target or biomarker in current literature[1][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ret finger protein-like 4A (RFPL4A).